HCEMM logo

HCEMM-SU Cardiovascular Comorbidities Research Group

Publications

Pub

2. Altered Cellular Protein Quality Control System Modulates Cardiomyocyte Function in Volume Overload-Induced Hypertrophy.

Gömöri K, Herwig M, Hassoun R, Budde H, Mostafi N, Delalat S, Modi S, Begovic M, Szabados T, Pipis J, Farkas-Morvay N, Leprán I, Kovács Á, Mügge A, Ferdinandy P, Görbe A, Bencsik P, Hamdani N.
Journal/Proc./Book: Atioxidants
Year: 2022
doi doiicon

Pub

1. Ca2+/calmodulin-dependent protein kinase II and protein kinase G oxidation contributes to impaired sarcomeric proteins in hypertrophy model.

Gömöri K, Herwig M, Budde H, Hassoun R, Mostafi N, Zhazykbayeva S, Sieme M, Modi S, Szabados T, Pipis J, Farkas-Morvay N, Leprán I, Ágoston G, Baczkó I, Kovács Á, Mügge A, Ferdinandy P, Görbe A, Bencsik P, Hamdani N.

Journal/Proc./Book: ESC Heart Fail
Year: 2022
Thematic Pillar: Metabolic and Cardiovascular Diseases
doi doiicon

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 739593. HCEMM supported by EU Programme: H2020-EU.4.a. – Teaming of excellent research institutions and low performing RDI regions. Project starting date was 1 April 2017.

EU Flag

Awards

Consortium

Semmelweis University logo
SZTE logo
National Research, Development and Innovation Office

About HCEMM

Hungarian Centre of Excellence for Molecular Medicine is a strong catalyst of reformative changes in biomedical science and in institutional research management.

National VAT number: 26307383-2-06
EU VAT number: HU26307383

Linkedin Facebook Twitter Instagram
kozadattar logo

Internal Policies

Contact Info

Search
Copyright © 2024 Hungarian Centre of Excellence for Molecular Medicine, all rights reserved. Hungarian Centre of Excellence for Molecular Medicine® and HCEMM® are registered trademarks of the the HCEMM Nonprofit Ltd.
This website uses cookies. For more information visit the Cookies & Privacy Policy page.
ACCEPT
Skip to content